Protein kinase C activity is acutely regulated by plasma glucose concentration in human monocytes in vivo

Diabetes

Volumn 48, Issue 6, 2000, Pages 1316-1322

  Ceolotto, Giulio ^a   Gallo, Alessandra ^a   Miola, Marina ^a   Sartori, Michelangelo ^a   Trevisan, Roberto ^a   Del Prato, Stefano ^a   Semplicini, Andrea ^a   Avogaro, Angelo ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b Cattedra di Malattie del Metabolismo   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; PROTEIN KINASE C;

ADULT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; ENZYME ACTIVATION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

BLOOD GLUCOSE; CALCIUM; DIABETES MELLITUS, TYPE 2; ENZYME ACTIVATION; HUMANS; INSULIN RESISTANCE; ISOENZYMES; MONOCYTES; PHOSPHOLIPIDS; PROTEIN KINASE C;

EID: 0345346385     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.6.1316     Document Type: Article

References (39)

1. Porte D, Schwartz MW: Diabetes complications: why is glucose potentially toxic? Science 272:699-700, 1996
2. Koya D, King GL: Protein kinase C activation and the development of diabetic complications. Diabetes 47:859-866, 1998
3. Shiba T, Inoguchi T, Sportsman JR, Heat WF, Bursell S, King GL: Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation. Am J Physiol 256:E783-E793, 1993
4. 2 and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci U S A 89:11059-11063, 1992
5. Craven PA, Davidson MC, DeRubertis FR: Increase in diacylglycerol mass in isolated glomeruli by glucose from de novo synthesis of glycerolipids. Diabetes 39:667-674, 1990
6. Williams B, Schrier RW: Characterization of glucose-induced in situ protein kinase C activity in cultured vascular smooth muscle cells. Diabetes 41: 1464-1472, 1993
7. Kreuzer J, Denger S, Schmidts A, Jahn L, Merten M, von Hodenberg E: Fibrinogen promotes monocyte adhesion via a protein kinase C dependent mechanism. J Mol Med 74:161-165, 1996
8. Kalra VK, Shen Y, Sultana C, Rattan V: Hypoxia induces PECAM-1 phosphorylation and transendothelial migration of monocytes. Am J Physiol 271: H2025-H2034, 1996
9. Morigi M, Angioletti S, Imberti B, Donadelli R, Micheletti G, Figliuzzi M, Remuzzi A, Zoja C, Remuzzi G: Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycaemia in a NIF-κB-dependent fashion. J Clin Invest 101:1905-1915, 1998
10. Ross R: The pathogenesis of atherosclerosis: a prospective study for the 1990s. Nature 362:801-809, 1993
11. Ikeda U, Takahashi M, Shimada K: Monocyte-endothelial cell interaction in atherogenesis and thrombosis. Clin Cardiol 21:11-14, 1998
12. Nishizuka Y: Protein kinase C and lipid signalling for sustained cellular responses. FASEB J 9:484-496, 1995
13. Rose G, Blackburn H, Gillum RF, Prineas RJ: Cardiovascular Survey Methods, 2nd edition. Geneva, World Health Organization, 1982
14. 2H2]glucose kinetics. Diabetes 38:845-853, 1989
15. Avogaro A, Vicini P, Valerio A, Caumo A, Cobelli C: The hot but not the cold minimal model allows precise assessment of insulin sensitivity in NIDDM subjects. Am J Physiol 270:E532-E540, 1996
16. Kuzuya H, Blix PM, Horwitz DL, Steiner DF, Rubenstein AH: Determination of free and total insulin and C-peptide in insulin treated diabetics. Diabetes 26:22-29, 1977
17. Cole RA, Soeldner JS, Dunn PJ, Bunn HF: A rapid method for the determination of glycosylated hemoglobins using high pressure liquid chromatography. Metabolism 35:289-301, 1978
18. Roschlau VP, Bernt E, Gruber W: Enzymatische bestimmung des gesamtcholesterins im serum. Klin Chem Klin Biochem 12:403-406, 1974
19. Wahlefeld AW: Triglycerides. Determination after enzymatic hydrolysis. In Methods of Enzymatic Analysis. Bergmeyer HU, Ed. New York, Academic Press, 1976
20. Kostner GM: Enzymatic determination of cholesterol in high density lipoprotein fractions prepared by polyanion precipitation. Clin Chem 22:695, 1976
21. Chang ZL, Beezhold DH: Protein kinase C activation in human monocytes regulation of PKC isoforms. Immunology 80:360-366, 1993
22. + exchange. Am J Physiol 272: C818-C826, 1997
23. 2+, phosphatidylinositol and phosphatidylinositol 4,5-bisphosphate. Biochem J 291:627-633, 1993
24. Consadine RV, Nyce MR, Allen LE, Morales LM, Triester S, Serrano J, Colberg J, Lanza-Jacoby S, Caro JF: Protein kinase C is increased in the liver of humans and rats with non-insulin-dependent diabetes mellitus: an alteration not due to hyperglycaemia. J Clin Invest 95:2938-2944, 1995
25. Schmitz-Peiffer C, Browne CL, Oakes ND, Watkinson A, Chisholm DJ, Kraegen EW, Biden TJ: Alterations in the expression and cellular localization of protein kinase C isozymes ε and φ are associated with insulin resistance in skeletal muscle of the high-fat-fed rat. Diabetes 46:169-177, 1997
26. Nagy K, Levy J, Grunenberger G: Impaired translocation of protein kinase C activity in human non-insulin-dependent diabetes mellitus. Metabolism 40:807-813, 1991
27. Heydrick SJ, Ruderman NB, Kurowski TG, Adams HB, Chen KS: Enhanced stimulation of diacylglycerol and lipid synthesis by insulin in denervated muscle. Altered protein kinase C activity and possible link to insulin resistance. Diabetes 40:1707-1711, 1991
28. Kunisaki M, Bursell S-E, Umeda F, Nawata H, King GL: Normalization of diacylglycerol-protein kinase C activation by vitamin E in aorta of diabetic rats and cultured rat smooth muscle cells exposed to elevated glucose levels. Diabetes 43:1372-1377, 1994
29. Avignon A, Yamada K, Zhou X, Spencer B, Cardona O, Saba-Siddique S, Galloway L, Standaert ML, Farese RV: Chronic activation of protein kinase C in soleus muscles and other tissues of insulin-resistant type II diabetic Goto-Kakizaki (GK), obese/aged, and obese/Zucker rats. A mechanism for inhibiting glycogen synthesis. Diabetes 45:1396-1404, 1996
30. Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clermont A, Bursell S-E, Kern TS, Ballas ML, Heath WF, Stramm LE, Feener EP, King GL: Amelioration of vascular dysfunctions in diabetic rats by an oral PKC β inhibitor. Science 272:728-731, 1996
31. Babazono T, Kapor-Drezgic J, Dlugosz JA, Whiteside C: Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells. Diabetes 47:668-676, 1998
32. Tang EY, Parker PJ, Beattle J, Houslay M: Diabetes induces selective alterations in the expression of protein kinase C isoforms in hepatocytes. FEBS Lett 326:117-123, 1993
33. + antiporter phenotype and turnover of immortalized lymphoblasts from type 1 diabetic patients with nephropathy. J Clin Invest 93:2750-2757, 1994
34. King GL, Kunisaki M, Nishio Y, Inoguchi T, Shiba T, Pu X: Biochemical and molecular mechanisms in the development of diabetic vascular complications. Diabetes 45 (Suppl. 3):S105-S108, 1996
35. Inoguchi T, Xia P, Kunisaki M, Higashi S, Feener PE, King GL: Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissues. Am J Physiol E369-E379, 1994
36. Muniyappa R, Srinivas PR, Ram JL, Walsh MF, Sowers JR: Calcium and protein kinase C mediate high-glucose-induced inhibition of inducible nitric oxide synthase in vascular smooth muscle cells. Hypertension 31:289-295, 1998
37. Pirags V, Assert R, Haupt K, Schatz H, Pfeiffer A: Activation of human platelet protein kinase C-beta 2 in vivo in response to acute hyperglycemia. Exp Clin Endocrinol Diabetes 104:431-440, 1996
38. Hoffman JM, Ishizuka T, Farese RV: Interrelated effects of insulin and glucose on diacylglycerol-protein kinase-C signalling in rat adipocytes and solei muscle in vitro and in vivo in diabetic rats. Endocrinology 128:2937-2948, 1991
39. Carantoni M, Abbasi E, Chu L, Chen YDI, Reaven GM, Tsao PS, Varasteh B, Cooke JP: Adherence of mononuclear cells to endothelium in vitro is increased in patients with NIDDM. Diabetes Care 20:1462-1469, 1997